Downregulation of ERBB4 signaling
Downstream signal transduction
Drug resistance in ERBB2 KD mutants
Drug resistance in ERBB2 TMD/JMD mutants
Drug-mediated inhibition of ERBB2 signaling
ERBB2 Activates PTK6 Signaling
Signaling by KIT in disease
Diseases of signal transduction by growth factor receptors and second messengers
Signaling by LTK
Signaling by MET
Synthesis, secretion, and deacylation of Ghrelin
Signal Transduction
Signaling by NTRK2 (TRKB)
MAPK1/MAPK3 signaling
MAPK family signaling cascades
Signaling by Leptin
SOS-mediated signalling
Signaling by CSF1 (M-CSF) in myeloid cells
Disease
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
Signaling by ERBB2
Signaling by ERBB2 ECD mutants
Signaling by ERBB2 KD Mutants
Signaling by ERBB2 TMD/JMD mutants
PI3K events in ERBB2 signaling
Signaling by EGFR
PI3K events in ERBB4 signaling
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
Signaling by ERBB4
Signaling by Erythropoietin
Signaling by EGFRvIII in Cancer
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1
Signaling by EGFR in Cancer
Signaling by ERBB2 in Cancer
SHC1 events in ERBB4 signaling
Signaling by Ligand-Responsive EGFR Variants in Cancer
Resistance of ERBB2 KD mutants to afatinib
IRS activation
InlB-mediated entry of Listeria monocytogenes into host cell
Resistance of ERBB2 KD mutants to trastuzumab
Resistance of ERBB2 KD mutants to tesevatinib
p130Cas linkage to MAPK signaling for integrins
Resistance of ERBB2 KD mutants to sapitinib
Activated NTRK2 signals through PI3K
Resistance of ERBB2 KD mutants to osimertinib
Signaling by Receptor Tyrosine Kinases
Activated NTRK3 signals through PI3K
Resistance of ERBB2 KD mutants to neratinib
Signaling by SCF-KIT
Resistance of ERBB2 KD mutants to lapatinib
Resistance of ERBB2 KD mutants to AEE788
Signaling by PDGF
Constitutive Signaling by EGFRvIII
GRB2 events in ERBB2 signaling
Signaling by NTRK3 (TRKC)
GAB1 signalosome
GRB2:SOS provides linkage to MAPK signaling for Integrins
Listeria monocytogenes entry into host cells
Interleukin-3, Interleukin-5 and GM-CSF signaling
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
Cell surface interactions at the vascular wall
RAF/MAP kinase cascade
Negative regulation of the PI3K/AKT network
Hemostasis
Signaling by CSF3 (G-CSF)
Constitutive Signaling by Aberrant PI3K in Cancer
FLT3 Signaling
VEGFA-VEGFR2 Pathway
Signaling by PTK6
Signaling by VEGF
Signaling by Non-Receptor Tyrosine Kinases
Cytokine Signaling in Immune system
Developmental Biology
Regulation of signaling by CBL
Integrin signaling
Signaling by PDGFR in disease
PI3K/AKT Signaling in Cancer
SHC1 events in ERBB2 signaling
PIP3 activates AKT signaling
Platelet Aggregation (Plug Formation)
FLT3 signaling in disease
DAP12 interactions
DAP12 signaling
Intracellular signaling by second messengers
Axon guidance
Signaling by FGFR3
SHC1 events in EGFR signaling
Tie2 Signaling
Nervous system development
Signaling by FGFR4
Signaling by NTRKs
Signaling by Interleukins
Signaling by FLT3 ITD and TKD mutants
Platelet activation, signaling and aggregation
Extra-nuclear estrogen signaling
Signaling by FGFR1 in disease
Signaling by FGFR1
Signaling by PDGFRA extracellular domain mutants
Signaling by FGFR4 in disease
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
Downstream signaling of activated FGFR3
Constitutive Signaling by Overexpressed ERBB2
Role of LAT2/NTAL/LAB on calcium mobilization
GRB2 events in EGFR signaling
Signaling by FGFR2
Fcgamma receptor (FCGR) dependent phagocytosis
Downstream signaling of activated FGFR4
Erythropoietin activates RAS
Signaling by FLT3 fusion proteins
Downstream signaling of activated FGFR1
ESR-mediated signaling
RET signaling
SHC-related events triggered by IGF1R
Immune System
Signaling by FGFR
Downstream signaling of activated FGFR2
IGF1R signaling cascade
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
MET promotes cell motility
Signaling by NTRK1 (TRKA)
Signaling by Nuclear Receptors
Signaling by FGFR in disease
Fc epsilon receptor (FCERI) signaling
Interleukin-2 family signaling
Regulation of T cell activation by CD28 family
IRS-related events triggered by IGF1R
MET activates RAS signaling
Inactivation of CSF3 (G-CSF) signaling
Insulin receptor signalling cascade
Signaling by FGFR3 in disease
Cell-Cell communication
Co-stimulation by CD28
FCERI mediated MAPK activation
Activated NTRK2 signals through RAS
Activated NTRK2 signals through FRS2 and FRS3
Activated NTRK3 signals through RAS
Downregulation of ERBB2 signaling
Infectious disease
Signaling by the B Cell Receptor (BCR)
Signaling by Insulin receptor
NCAM signaling for neurite out-growth
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
EGFR downregulation
EGFR Transactivation by Gastrin
Signaling by cytosolic FGFR1 fusion mutants
Signaling by ALK in cancer
Signaling by ALK fusions and activated point mutants
Signalling to ERKs
Innate Immune System
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
Adaptive Immune System
Signaling by FGFR2 in disease
IRS-mediated signalling
Leishmania phagocytosis
FCGR3A-mediated phagocytosis
Parasite infection
ERBB2 Regulates Cell Motility
MET activates PI3K/AKT signaling
PECAM1 interactions
Erythropoietin activates Phosphoinositide-3-kinase (PI3K)
Signalling to RAS
Interleukin-15 signaling
GPVI-mediated activation cascade
Interleukin-20 family signaling
Regulation of KIT signaling
Netrin-1 signaling
GPCR downstream signalling
Bacterial Infection Pathways
Signaling by ALK
Interleukin receptor SHC signaling
Response of endothelial cells to shear stress
Signal attenuation
MET activates RAP1 and RAC1
VEGFR2 mediated cell proliferation
Cellular responses to mechanical stimuli
EPHB-mediated forward signaling
FCERI mediated Ca+2 mobilization
Gastrin-CREB signalling pathway via PKC and MAPK
Interleukin-6 family signaling
MET receptor recycling
Interleukin-6 signaling
MET activates PTPN11
PLCG1 events in ERBB2 signaling
EGFR interacts with phospholipase C-gamma
FCGR activation
Growth hormone receptor signaling
Interleukin-7 signaling
SHC-mediated cascade:FGFR3
FRS-mediated FGFR3 signaling
FGFR1 mutant receptor activation
FRS-mediated FGFR4 signaling
SHC-mediated cascade:FGFR4
Co-inhibition by CTLA4
High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells
G alpha (q) signalling events
SHC-mediated cascade:FGFR1
FRS-mediated FGFR1 signaling
Parasitic Infection Pathways
Leishmania infection
STAT5 Activation
Signal regulatory protein family interactions
Regulation of actin dynamics for phagocytic cup formation
SHC-mediated cascade:FGFR2
FRS-mediated FGFR2 signaling
FCGR3A-mediated IL10 synthesis
CD28 dependent PI3K/Akt signaling
CD209 (DC-SIGN) signaling
PI-3K cascade:FGFR3
PI-3K cascade:FGFR4
Role of phospholipids in phagocytosis
DCC mediated attractive signaling
Erythropoietin activates STAT5
MET activates PTK2 signaling
Spry regulation of FGF signaling
Interleukin-2 signaling
C-type lectin receptors (CLRs)
Interleukin-4 and Interleukin-13 signaling
PI-3K cascade:FGFR1
Signaling by RAS GAP mutants
Signaling by Overexpressed Wild-Type EGFR in Cancer
Signaling by RAS GTPase mutants
Activation of RAS in B cells
PI3K/AKT activation
Inhibition of Signaling by Overexpressed EGFR
RAS GTPase cycle mutants
InlA-mediated entry of Listeria monocytogenes into host cells
Paradoxical activation of RAF signaling by kinase inactive BRAF
Signaling downstream of RAS mutants
Signaling by RAF1 mutants
Signaling by RAS mutants
Signaling by moderate kinase activity BRAF mutants
Signaling by GPCR
Prolactin receptor signaling
Interleukin-9 signaling
STAT5 activation downstream of FLT3 ITD mutants
EPH-Ephrin signaling
Signaling by BRAF and RAF1 fusions
MAP2K and MAPK activation
Signaling by high-kinase activity BRAF mutants
PI-3K cascade:FGFR2
Interleukin-21 signaling
Integrin cell surface interactions
Oncogenic MAPK signaling
PI3K Cascade
Anti-inflammatory response favouring Leishmania parasite infection
Leishmania parasite growth and survival
Negative regulation of MET activity
Estrogen-stimulated signaling through PRKCZ
CD28 dependent Vav1 pathway
Co-stimulation by ICOS
Nuclear signaling by ERBB4
RAS signaling downstream of NF1 loss-of-function variants
Estrogen-dependent nuclear events downstream of ESR-membrane signaling
Potential therapeutics for SARS
